Aberrant expression of CD95 and CD69 molecules among CD56+ cells in women with endometriosis

American Journal of Reproductive Immunology

Volumn 55, Issue 4, 2006, Pages 276-281

  Eidukaite, Audrone ^a   Siaurys, Almantas ^a   Tamosiunas, Vytas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

CD56+ cells; CD69 and CD95 molecules; Endometriosis; Natural killer; Peritoneal fluid

Indexed keywords

CD56 ANTIGEN; CD69 ANTIGEN; FAS ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ASCITIC FLUID; ENDOMETRIOSIS; FEMALE; HUMANS; KILLER CELLS, NATURAL; T-LYMPHOCYTE SUBSETS;

EID: 33644811699     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00360.x     Document Type: Article

References (26)

1. Ungefroren H, Voss M, Jansen M, Roeder C, Hennebruns D, Kremer B, Kaithoff N: Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998; 58: 1741-1749.
2. Kauma SW, Huff TF, Hayes N, Nilkaeo A: Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus. J Clin Endocrinol Metabol 1999; 84: 2188-2194.
3. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR: Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991; 56: 45-51.
4. Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR: The natural killer activity of peritoneal fluid lumphocytes is decreased in women with endometriosis. Fertil Steril 1992; 58: 290-295.
5. Tanaka E, Sendo F, Kawagoe S, Hirai M: Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992; 34: 27-30.
6. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I: Decreased natural killer cell activity in endometriosis patients: Relationship to disease pathogenesis. Fertil Steril 1994; 62: 1086-1088.
7. Garzetti GG, Cignitti M, Ciavattini A, Fabris N, Romanini C: Decreased natural killer cell activity in women with endometriosis. Gynecol Obstet Invest 1992; 34: 27-30.
8. American Society for Reproductive Medicine. Revised classification of endometriosis. Fertil Steril 1997; 67: 817-821.
9. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
10. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
11. Pisegna S, Zingoni A, Pirozzi G, Cinque B, Cifone MG, Morrone S, Piccoli M, Frati L, Palmieri G, Santoni A: Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells. J Immunol 2002; 1: 68-74.
12. Oanchez-Madrid F: CD69: overview. In: Leukocyte Typing V, Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds). Oxford, UK, Oxford University Press, 1995, pp 1126.
13. Testi R, D'AmArosio D, De Maria R, Santoni A: The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994; 15: 479-483.
14. Gavioli R, Risso A, Smilovich D, Baldissarro I, Capra MC, Bargellesi A, Consulich ME: CD69 molecule inIhuman neutrophils: its expression and role in signal-transducing mechanisms. Cell Immunol 1992; 142: 186-196.
15. Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni A: CD69 is expressed on platelets and mediates platelet activation and aggregation. J Exp Med 1990; 172: 701-707.
16. Sanchez-Mateos P, Cebrian M, Acevedo A, Lopez-Botet M, De Landazuri MO, Sanchez-Madrid F: Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues: Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. Immunol 1989; 68: 72-79.
17. Kishimoto H, Surh CD, Sprent J: Upregulation of surface markers on dying thymocytes. J Exp Med 1995; 181: 649-655.
18. Nagata S: Fas And Fas ligand: a death factor, and its receptor. Adv Immunol 1994; 57: 129-144.
19. Griffith TS, Ferguson TA: The role of FasL-induced apoptosis in immune privilege. Immunol Today 1997; 18: 240-244.
20. Selam B, Kayisli UA, Garcia-Velasco JA, Arici A: Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod 2002; 66: 1-5.
21. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G: Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: A role in endometriosis. Molec Hum Reprod 1999; 5: 642-650.
22. Linghu H, Xu X, Luo J, Zhuang L: Changes of soluble fas and soluble fas ligand in serum and peritoneal fluid of infertile patients with endometriosis. Chin Med Sci J 2004; 19: 56-59.
23. Vigano P, Gaffuri B, Somigliana E, Busacca M, Di Blasio AM, Vignali M: Expression of intercellular adhesion molecule (ICAM)-1 mRNA and protein is enhanced in endometriosis versus endometrial stromal cells in culture. Mol Hum Reprod 1998; 4: 1150-1156.
24. Mazzeo D, Vigano P, Di Blasio AM, Sinigaglia F, Vignali M, Panina-Bordignon P: Intyerleukin-12 and its free p40 subunit regulate immune recognition of endometrial cells: Potential role in endometriosis. J Clin Endocrinol Metabol 1998; 83: 911-916.
25. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T: Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 2002; 77: 297-302.
26. Long EO: Regulation of immune responses through inhibitory receptors. Ann Rev Immunol 1999; 17: 875-904.